sb 203580 has been researched along with Intestinal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, LL; Huang, HY; Huang, XZ; Li, ZR; Lin, J; Zhu, LB | 1 |
| Chen, JD; Gan, HT; Pasricha, PJ | 1 |
2 other study(ies) available for sb 203580 and Intestinal Diseases
| Article | Year |
|---|---|
Inhibition of p38 mitogen-activated protein kinase attenuates butyrate-induced intestinal barrier impairment in a Caco-2 cell monolayer model.
Topics: Annexin A5; Apoptosis; Butyrates; Caco-2 Cells; Electric Impedance; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Humans; Imidazoles; Intestinal Absorption; Intestinal Diseases; Intestinal Mucosa; Inulin; p38 Mitogen-Activated Protein Kinases; Permeability; Phosphorylation; Pyridines | 2014 |
Blockade of p38 mitogen-activated protein kinase pathway ameliorates delayed intestinal transit in burned rats.
Topics: Animals; Burns; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Gastrointestinal Transit; Imidazoles; Intestinal Diseases; Male; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiourea | 2007 |